Meet the governmental life science office

More clinical trials, promotion for digitisation and interoperability together with increased use of data generated by both healthcare and individuals. The duti...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

CAR-T therapies give continued hope: “Almost half of the patients have become disease-free”

When the first CAR-T therapies appeared, hopes were raised for the effective treatment for critically ill cancer patients. After a somewhat sluggish start, abou...

Engage with your CMO early

Gordon Hutton is Materials Science Lead at Thermo Fisher Scientific’s, formerly GSK, small molecule API site in Cork, Ireland.

Helena Strigård: The rise of the community

Sweden Bio´s CEO is looking back at the last decade of development in the industry. Something has shifted in the interdependence between small and larger companies.

Your partnering tool - step by step

Profile, agenda and requests. Those are the basic steps to follow to use the partnering tool for Biotech Forum. Follow our guide to successful partnering!

Orexo vinner långdragen patenttvist

Amerikanska domstolen för överklagande slår fast att bolagets långa patent för Zubsolv är giltigt. Tidigare beslut som förklarade patentet ogiltigt rivs alltså upp.

Pharma-on-Demand

Make or buy? That is the question that the pharma world has been asking more and more in the last couple of decades. Pernille Hemmingsen is moderator at Pharma ...

Bakom de gröna ambitionerna

Många läkemedelsföretag inkluderar i dag ett miljötänk i tillverkningen av läkemedel. Men få är villiga att redovisa faktiska siffror i Life Science Swedens enk...

Product Specialist at Gradientech AB, Uppsala

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

Opinion: Where do all the cool Swedish life science companies go?

It’s puzzling why Swedish life science companies hardly get a mention alongside Spotify, Skype, Klarna, King, iZettle, and other cool, innovative and successful...

With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

The best wealth is Health

We are living in a world where wealth more and more is measured in being able to do the things you like and enjoy in life. As the wealth increases in terms of e...

New partnering platform

EBD Group's Partnering One is the new partnering platform for Biotech Forum 2009.

Swedish life science in political focus

It feels like 2017 will be a good year for Swedish life science, says Anders Blanck, CEO at LIF.

Einar Pontén, Managing Director, Merck Sequant

Why are you going to Scanlab+Biotech Forum?

Krönika: Collaboration across borders

Per Hammargren, Sales Director, ICU Scandinavia AB

Why are you going to Scanlab and Biotech Forum?

Academia - a strong player on the lab market

While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...

Clinical trials in large scale to Stockholm

Karolinska Trial Alliance, KTA, will open a medical clinical for clinical trials in Phases II-IV. The clinic will be able to accommodate up to 150 patients per ...

Symphogen buys tumor blocking technology

The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...

Gabor Fischer, Distribution Sales Manager Europe, Ismatec

Why are you going to Scanlab+Biotech Forum?

Per Norstedt, Regional Manager, AH Diagnostics

Why are you going to Scanlab+Biotech Forum?